The team is optimizing the cancer genome analysis system to integrate it into CRC diagnosis and tailor treatments based on ...

Dr. Mohamed Fareh and colleagues have shown it is possible to silence the KRAS G12, NRAS G12D, and BRAF V600E gene mutations known to drive aggressive pancreatic, colorectal and lung cancers.

Researchers used mutational analysis to identify gene mutations that may drive carcinogenesis in colorectal tumors with high ...

Cancer patients invariably develop resistance to targeted drugs, so drugmakers develop strategies to combat it before ...

Colorectal cancer (CRC), a type of cancer that affects the large intestine and rectum, is one of the leading causes of cancer ...

Biomarkers, precision medicine, early detection to revolutionize CRC care in India: Dr. Sumant Gupta: Shardul Nautiyal, ...

My research is aimed at developing optimal therapies to treat cancers that harbor BRAF or KRAS mutations, as well as at understanding how these proteins affect intracellular signaling and cellular ...